Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

62.27
-0.7800-1.24%
Post-market: 61.85-0.4200-0.67%18:29 EDT
Volume:6.23M
Turnover:392.00M
Market Cap:11.24B
PE:-43.43
High:65.79
Open:65.64
Low:61.22
Close:63.05
52wk High:104.32
52wk Low:40.77
Shares:180.43M
Float Shares:115.00M
Volume Ratio:0.85
T/O Rate:5.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:25.25
PE(LYR):-44.16

Loading ...

Tempus AI announce strategic collaboration with Gilead

TIPRANKS
·
Apr 09

BUZZ-Tempus AI rises as it expands cancer research partnership with Gilead

Reuters
·
Apr 09

Tempus Announces Strategic Collaboration With Gilead to Advance Oncology R&D Through RWE

THOMSON REUTERS
·
Apr 09

Tempus expands multi-year oncology RWE collaboration with Gilead Sciences

Reuters
·
Apr 09

Tempus AI CFO to speak at Needham Virtual Healthcare Conference

Reuters
·
Apr 09

Tempus AI announces annual shareholder meeting webcast

Reuters
·
Apr 08

Fastmarkets proposes to amend publication times for China TEM prices: pricing notice

Fastmarkets
·
Apr 02

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences

Reuters
·
Apr 02

Stock Track | Tempus AI Soars 5.04% Intraday on Positive ALERT Trial Results Showing AI EHR Alerts Improve Heart Disease Treatment

Stock Track
·
Apr 01

BRIEF-Tempus And Medtronic Announce Alert Trial Results Showing Ai-Driven Ehr Notifications Improve Treatment For Significant Valvular Heart Disease

Reuters
·
Apr 01

Tempus AI announces results from ALERT trial, study met primary endpoint

TIPRANKS
·
Apr 01

Tempus- Medtronic ALERT trial shows AI EHR alerts lift valve interventions 40%

Reuters
·
Apr 01

Tempus AI Inc: Study Met Its Primary Endpoint, Demonstrating That Automated Ecn Alerts Were Superior to Usual Care in a Win Ratio Analysis

THOMSON REUTERS
·
Apr 01

Tempus and Medtronic Announce Alert Trial Results Showing AI-Driven Ehr Notifications Improve Treatment for Significant Valvular Heart Disease

THOMSON REUTERS
·
Apr 01

Tempus AI Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 30

Tempus AI price target lowered to $60 from $95 at Guggenheim

TIPRANKS
·
Mar 30

Tempus AI CEO Eric Lefkofsky disposes of shares worth USD 7.66 million

Reuters
·
Mar 28

Meta Stock Dumped by Cathie Wood. Her ARK Funds Go Big On This AI Play Instead

Dow Jones
·
Mar 26

Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares

Benzinga
·
Mar 26

Tempus Announces Strategic Collaboration With Daiichi Sankyo To Advance Ai-Driven Biomarker Discovery And Clinical Differentiation Across An Adc Clinical Program

Reuters
·
Mar 25